HomeINDV • NASDAQ
add
Indivior Pharmaceuticals, Inc
Nakaraang pagsara
$32.31
Sakop ng araw
$30.44 - $32.76
Sakop ng taon
$8.69 - $38.00
Market cap
3.72B USD
Average na Volume
3.23M
P/E ratio
31.84
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 358.00M | 19.73% |
Gastos sa pagpapatakbo | 169.00M | -14.21% |
Net na kita | 102.00M | 385.71% |
Net profit margin | 28.49 | 305.84% |
Kita sa bawat share | 0.82 | 157.13% |
EBITDA | 135.00M | 145.45% |
Aktuwal na % ng binabayarang buwis | -25.93% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 195.00M | -39.06% |
Kabuuang asset | 1.20B | -8.74% |
Kabuuang sagutin | 1.30B | -21.42% |
Kabuuang equity | -98.00M | — |
Natitirang share | 125.07M | — |
Presyo para makapag-book | -41.42 | — |
Return on assets | 25.41% | — |
Return on capital | 165.42% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 102.00M | 385.71% |
Cash mula sa mga operasyon | -221.00M | -1,200.00% |
Cash mula sa pag-invest | -24.00M | -400.00% |
Cash mula sa financing | -5.00M | -112.50% |
Net change in cash | -250.00M | -881.25% |
Malayang cash flow | 23.38M | 142.50% |
Tungkol
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
Itinatag
Set 26, 2014
Website
Mga Empleyado
833
